| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
23.4260 | 23.4260 | 0 | 0 |
| Cost of Revenue
|
-7.9650 | -7.9650 | 0 | -- |
|
Gross Profit
|
15.4610 | 15.4610 | 0 | -- |
| Selling, General and Administrative Expenses
|
-53,870.6880 | -53,870.6880 | -20,730.7910 | -10,548.2780 |
|
Research and Development Expenses
|
-10,264.1230 | -10,264.1230 | -6,310.6080 | -4,261.5320 |
| Depreciation, Amortization and Depletion
|
-2,097.2250 | -2,097.2250 | -1,876.4820 | -1,850.1830 |
|
Operating Income/Expenses
|
-66,232.0360 | -66,232.0360 | -28,917.8810 | -16,659.9930 |
|
Total Operating Profit/Loss
|
-66,216.5750 | -66,216.5750 | -28,917.8810 | -16,659.9930 |
| Total Net Finance Income/Expense
|
-3.5520 | -3.5520 | -0.2910 | -1.0900 |
| Net Investment Income
|
-41.5450 | -41.5450 | 624.1540 | -1,049.5740 |
| Irregular Income/Expenses
|
-799.1680 | -799.1680 | -474.5380 | 0 |
|
Other Income/Expense, Non-Operating
|
54.2470 | 54.2470 | 14.8110 | 54.3490 |
|
Non-Operating Income/Expenses, Total
|
-790.0180 | -790.0180 | 164.1360 | -996.3150 |
|
Pretax Income
|
-67,006.5930 | -67,006.5930 | -28,753.7450 | -17,656.3080 |
|
Provision for Income Tax
|
392.6030 | 392.6030 | 620.7740 | 1,112.0700 |
|
Net Income from Continuing Operations
|
-66,613.9900 | -66,613.9900 | -28,132.9710 | -16,544.2380 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-66,613.9900 | -66,613.9900 | -28,132.9710 | -16,544.2380 |
|
Net Income after Non-Controlling/Minority Interests
|
-66,613.9900 | -66,613.9900 | -28,132.9710 | -16,544.2380 |
|
Net Income Available to Common Stockholders
|
-66,613.9900 | -66,613.9900 | -28,132.9710 | -16,544.2380 |
|
Diluted Net Income Available to Common Stockholders
|
-66,613.9900 | -66,613.9900 | -28,132.9710 | -16,544.2380 |
| Basic EPS
|
-0.47 | -0.47 | -- | -- |
| Diluted EPS
|
-0.47 | -0.47 | -- | -- |
|
Basic Weighted Average Shares Outstanding
|
141,407.8130 | 141,407.8130 | -- | -- |
|
Diluted Weighted Average Shares Outstanding
|
141,407.8130 | 141,407.8130 | -- | -- |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-67,003.0410 | -67,003.0410 | -28,753.4540 | -17,655.2180 |
|
EBITDA
|
-65,030.4870 | -65,030.4870 | -26,876.9720 | -15,805.0350 |
|
Normalized EBITDA
|
-11,627.2690 | -11,627.2690 | -8,778.9710 | -7,684.4720 |
|
Normalized Income
|
-13,523.6615 | -13,523.6615 | -10,425.6877 | -8,935.1405 |
|
Total Unusual Items
|
53,403.2180 | 53,403.2180 | 18,098.0010 | 8,120.5630 |
12/31/2023 - 9/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade